[Experience in using ecdisten in the treatment of hymenolepiasis]

The paper presents the results of clinical and parasitological studies in 22 patients with hymenolepiasis after treatment with ecdisten. The drug was used in a dose of 5 ml thrice a day during two weeks. It normalized all clinical symptoms in 8 patients and improved most of them in other patients. The results of helminthoovoscopy were interpreted in terms of clinical data. The parasitological efficacy of ecdisten is 36.4%. Its good tolerance, no contraindications, and easiness-to-use permit the drug to be recommended as a supplementary health-improving medication.